BioCentury
ARTICLE | Company News

Oxxon and Ludwig in research agreement

December 13, 2000 8:00 AM UTC

Oxxon Pharmaccines (Oxford, U.K.) will license certain cancer antigens from the Ludwig Institute for Cancer Research (Oxford, U.K.) for use in Oxxon's therapeutic cancer vaccines. ...